EN DE
Watch GP-Act III Acquisition Corp. Class A Ordinary Share for free: we tell you when fair value or trend changes.
Data-driven stock valuation

GP-Act III Acquisition Corp. Class A (GPAT) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of GP-Act III Acquisition Corp. Class A stock $11.58, price $11.06, upside +4.7%, quality 55 out of 100. Rating: fairly valued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Financial Services US · ISIN KYG4035N1034

GA GP-Act III Acquisition Corp. Class A logo Thin data Nov 8, 2026

GP-Act III Acquisition Corp. Class A

GPAT · US
Fairly valued, in an uptrend

The stock costs about what our calculation considers fair.

Ranks above peers (6/8)
Fair value $11.58 · Fairly valued (+4.7%)
Quality 55/100
Negative free cash flow
Narrow moat 34/100 · thin data
Thin data
Watch GP-Act III Acquisition Corp. Class A Ordinary Share for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$11.16 $9.98 Fair Value $11.58 Jul 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

28‑month range $9.98 – $11.16 · fair‑value band $7.17 – $12.20 · the $11.06 price screens below the $11.58 fair value. As of Nov 8, 2026.

Follow GP-Act III Acquisition Corp. Class A Ordinary Share in your weekly email

Every Wednesday you see whether GP-Act III Acquisition Corp. Class A Ordinary Share is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp.

Show moreShow less

II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

Stock analysis

GP-Act III Acquisition Corp. Class A (GPAT) currently trades at $11.06, while our model-based Fair Value estimate is $11.58, so the stock looks roughly fairly valued today (gap 4.5%).

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $17.55 per share, and 4 of the 6 models we run sit above the $11.06 price.

Bear case: the Earnings-Based group reads lowest at $8.50, and 2 of the 6 models stay below the price. Data coverage for this calculation is low.

Scenario range: $7.17 (bear) to $12.20 (bull), the price of $11.06 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 55/100 (solid quality), in the Financial Services sector.

GP-Act III Acquisition Corp. Class A Ordinary Share reported revenue of $0 in FY2025 versus $0 in FY2022. Reported net income was $11.9M in FY2025.

Key figures

Market cap $253M Micro · P/E ratio 44.2 · EPS (TTM) $0.2500 · Return on equity 9.8% · Return on assets (EBIT) −1.5% (5-year average) · EPS growth (YoY) −86.2% · Free cash flow −$372K · Net debt $287K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 34 out of 100 (low confidence).

What moves the price

The share trades about 1% below its 52-week high and 4% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −51% fair-value upside, at 5%, GPAT screens cheaper than that median.

Fair Value models

Bear $7.17 Fair Value $11.58 Bull $12.20
Price $11.06 · Upside +4.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($0.2137 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
P/E Multiple $7.17 $9.57 $11.96 63
Residual Income $11.51 $11.58 $12.20 61
P/B Multiple $19.15 $25.53 $31.91 55
All 6 models by family
Earnings-Based
Graham-Dodd $5.00 $13.31 $17.40 51
Lynch FV $2.58 $3.68 $4.78 48
Multiples
P/E Multiple $7.17 $9.57 $11.96 63
P/B Multiple $19.15 $25.53 $31.91 55
Asset-Based
NCAV (Graham) $9.12 $12.22 $18.23 51
Economic Profit
Residual Income $11.51 $11.58 $12.20 61

Open the full fair value analysis →

Quality Score breakdown

Overall quality 55/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 21
How much profit the company makes from its sales and capital
Quality Growth 55
Are margins and returns getting better?
Cashflow 100
Do the profits arrive as real cash?
Financial strength 67
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 100
How calm the share price moves, does not count
Price momentum 42
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 59
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Watch GPAT, get fair value alerts →

Compare GP-Act III Acquisition Corp. Class A Ordinary Share with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Shell Companies · 30 stocks

Beats the industry median on 6/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 55 · Below median
Fair Value upside +4.7% · Above median
Profitability
Return on equity (12 months) 9.8% · Above median
Return on assets 3.8% · Above median
Operating margin (12 months) 0.0% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Top 25%

Valuation Multiplesvs Shell Companies median · lower = cheaper

P/E (12 months) 44.2× · Pricier than median
P/B 0.86× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)40 · sector 0
FUTURE (revenue growth)0 · sector 0
PAST (return on equity)39 · sector 0
HEALTH (low debt)0 · sector 0
DIVIDEND (yield)0 · sector 0

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Shell Companies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Metals Acquisition Corp MTAL $10.14 $17.24 +70% vs GPAT
AA Mission Acquisition Corp AAM $0.0300 $0.0390 +30% vs GPAT
TGE Value Creative Solutions Corp BEBE $10.07 $8.20 −19% vs GPAT
Lionheart III Corp LION $14.24 $9.72 −32% vs GPAT
Lionheart Holdings CUB $10.95 $5.41 −51% vs GPAT
Texas Ventures Acquisition III Corp TVACW $0.1501 $0.0680 −55% vs GPAT
Translational Development Acquisition Corp TDAC $10.87 $4.28 −61% vs GPAT
Berto Acquisition Corp TACO $10.50 $2.32 −78% vs GPAT
Vylor Inc VYLR $70.14 $14.28 −80% vs GPAT
Axiom Intelligence Acquisition Corp AXIN $10.40 $1.24 −88% vs GPAT

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

GP-Act III Acquisition Corp. Class A Ordinary Share: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "GP-Act III Acquisition Corp. Class A Ordinary Share Fair Value". https://www.fairvalue-calculator.com/stock/GPAT

Frequently asked questions

Is GP-Act III Acquisition Corp. Class A (GPAT) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of $11.58 versus a price of $11.06, about +5% upside (fairly valued).
What is the fair value of GPAT?
Our model-based fair value for GP-Act III Acquisition Corp. Class A is $11.58 (as of Nov 8, 2026), built from audited fundamentals. The current price: $11.06.
What is the quality score of GPAT?
GP-Act III Acquisition Corp. Class A has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for GP-Act III Acquisition Corp. Class A (GPAT)?
Our model-based price target is the fair value of $11.58 (as of Nov 8, 2026) from 6 valuation models. Cautious scenario $7.17, optimistic scenario $12.20. It is a calculation from audited fundamentals, not an analyst target.
What is the GP-Act III Acquisition Corp. Class A Ordinary Share stock forecast for 2026?
Our models put fair value at $11.58, about +5% upside versus a price of $11.06 (fairly valued). Cautious scenario $7.17, optimistic scenario $12.20. The calculation is refreshed regularly with new filings.
What is the intrinsic value of GP-Act III Acquisition Corp. Class A (GPAT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For GP-Act III Acquisition Corp. Class A it is $11.58 per share (as of Nov 8, 2026), against a price of $11.06. It is the blended result of 6 valuation models in 4 families (Earnings-Based, Multiples, Asset-Based, Economic Profit).
Is GP-Act III Acquisition Corp. Class A Ordinary Share stock overvalued or undervalued in 2026?
As of Nov 8, 2026, GPAT trades below its calculated fair value: price $11.06, fair value $11.58, a gap of about +5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GPAT?
No. The price is what the market pays today ($11.06); the fair value is what the company's own numbers justify ($11.58). For GP-Act III Acquisition Corp. Class A the two are $0.5200 per share apart. That gap is exactly why we show both numbers side by side.
How much is GP-Act III Acquisition Corp. Class A Ordinary Share worth?
The market values GP-Act III Acquisition Corp. Class A at about $253M (market capitalisation, as of Nov 8, 2026). Per share that is $11.06; our models calculate a fair value of $11.58 per share.
What do the bullish and bearish scenarios say about GPAT?
Our models span a range for GP-Act III Acquisition Corp. Class A: cautious scenario $7.17, base $11.58, optimistic $12.20 per share (as of Nov 8, 2026, price $11.06). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GPAT?
GP-Act III Acquisition Corp. Class A trades at a price-to-earnings ratio of 44.2 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $11.58 is built from several models across several years. Other multiples: P/B 0.9.
How solid is the balance sheet of GP-Act III Acquisition Corp. Class A (GPAT)?
Balance-sheet figures for GP-Act III Acquisition Corp. Class A (as of Nov 8, 2026): return on equity 9.8%. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is GPAT from its 52-week high?
GP-Act III Acquisition Corp. Class A trades at $11.06, about 1% below its 52-week high of $11.16 and 4% above the low of $10.65 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $11.58 is for.
Which stocks are comparable to GP-Act III Acquisition Corp. Class A Ordinary Share?
From the same area (Financial Services) we also value Vylor Inc, Lionheart III Corp, AA Mission Acquisition Corp, Berto Acquisition Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is GP-Act III Acquisition Corp. Class A Ordinary Share stock attractive at the current price?
The data as of Nov 8, 2026: price $11.06, calculated fair value $11.58 (+5%), Quality Score 55/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GPAT calculated?
We run GP-Act III Acquisition Corp. Class A through 6 models from 4 families: Earnings-Based, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of $11.58 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. GP-Act III Acquisition Corp. Class A currently trades 4% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of GP-Act III Acquisition Corp. Class A (GPAT)?
The closing price on Nov 6, 2026 was $11.06. Our model-based fair value is $11.58, about +5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with GP-Act III Acquisition Corp. Class A Ordinary Share right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of GP-Act III Acquisition Corp. Class A

How large is the market capitalisation of GP-Act III Acquisition Corp. Class A (GPAT)?
The market capitalisation of GP-Act III Acquisition Corp. Class A is $253M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of GP-Act III Acquisition Corp. Class A (GPAT)?
Earnings per share at GP-Act III Acquisition Corp. Class A are $0.2500 (price ÷ EPS = P/E 44.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of GP-Act III Acquisition Corp. Class A (GPAT)?
The return on equity (ROE) of GP-Act III Acquisition Corp. Class A is 9.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of GP-Act III Acquisition Corp. Class A (GPAT)?
On an EBIT basis the return on assets of GP-Act III Acquisition Corp. Class A is −1.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How fast are earnings growing at GP-Act III Acquisition Corp. Class A (GPAT)?
Earnings per share at GP-Act III Acquisition Corp. Class A are growing −86.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does GP-Act III Acquisition Corp. Class A (GPAT) generate?
The free cash flow of GP-Act III Acquisition Corp. Class A is −$372K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does GP-Act III Acquisition Corp. Class A (GPAT) carry?
The net debt of GP-Act III Acquisition Corp. Class A is $287K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch GP-Act III Acquisition Corp. Class A Ordinary Share in the live analysis

One click puts GP-Act III Acquisition Corp. Class A Ordinary Share on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.